Stock Screener App

Frei -

Installieren

10.31

2.38% 0.24

after-market

Handel nachbörslich: 10.29 -0.02 -0.19%

Xeris Biopharma Holdings Inc (XERS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.79% 92.10	83.13	85.81	74.38	71.54
Selling, General, and Administrative	14.85% 61.03	53.14	-	-	-
Operating Income/Loss	34.65% 5.173	7.916	16.77	6.731	4.482
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	1,492% -31.10	2.234	11.08	0.621	-1.928
Basic Average Shares	1.35% 172.82	170.52	1.8657	163.65	159.46
Diluted Average Shares	2.71% 172.82	177.63	14.18	177.62	159.46
Basic Earnings Per Share	1,900% -0.18	0.01	0.07	-	-0.01
Diluted Earnings Per Share	1,900% -0.18	0.01	0.07	-	-0.01

TRLV

$10.01

2.82%

ALVO

$5.00

5.84%

BCRX

$7.79

2.87%

ANIP

$72.29

0.01%

PAHC

$38.82

2.21%

SUPN

$37.88

4.27%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters